Introduction
In 2004, according to the World Health Organization, approximately 640 000 children under the age of 15 years were infected with HIV worldwide [1] . Mother-to-child transmission (MTCT) of HIV, which can occur during intrauterine life, during delivery, or through breastfeeding, accounts for approximately 90% of all HIV infections among these children [2] . Approximately 2 million HIVpositive pregnant women were in need of prevention measures against MTCT of HIV in 2003, but only 9% of these women received such interventions. In sub-Saharan Africa, this rate was much less [2] .
In the absence of preventative interventions, namely antiretroviral treatment during pregnancy and delivery and for the newborn and avoiding breastfeeding, up to 32.5% of children born to HIV-positive mothers become infected [3] . Of these, 15-20% occur during pregnancy, over 50% occur during labour and delivery, and up to 29% occur during breastfeeding [4, 5] . In the period before the availability of preventative interventions, the rates of MTCT of HIV varied greatly: 11-14% in western Europe, 20-28% in the United States, and 30-35% in certain African countries [2] . Data available in Brazil indicate rates between 13 and 20%, depending on breastfeeding practices [6] .
Throughout the evolution of the epidemic, a number of advances have been incorporated into the care of HIVpositive individuals, especially HIV-infected pregnant women. Advances in the prophylaxis, treatment, and care provided to these women has changed the rates of MTCT. In 1994, the Pediatric Aids Clinical Trials Group (PACTG 076) [3] demonstrated the preventative efficacy of administering zidovudine to the mother in the prenatal period and during delivery, and administering it to the newborn for 6 weeks after delivery. The rate of MTCTof HIV in settings that offered high-quality diagnostic and clinical care along with access to medications from the beginning of prenatal care has subsequently been reduced to levels close to 2% [7] [8] [9] . Such interventions are widely available in developed countries. Brazil was one of the first developing countries to implement antiretroviral therapy for HIV in general and for the prevention of MTCTof HIV [10] (Table 1) [11, 12] . In Brazil, access to prophylactic treatment with zidovudine at the time of delivery for HIV-positive women was estimated to be 49% in 2003 [13] .
São Paulo State, with a population of 39 876 000, has the largest percentage of reported AIDS cases in Brazil (i.e. 42.3%) and the highest number of MTCT cases nationwide (40.3%) [14, 15] . São Paulo State was the first Brazilian state to implement specialized services for the care of HIV/AIDS patients, as early as 1983 [10] . Intervention strategies for the reduction of MTCT of HIV that have been introduced and implemented in São Paulo State, following the recommendations of the Brazilian STD/AIDS programme, include: specialized care (services that work with multiprofessional teams to assist individuals living with HIV/AIDS); training of healthcare professionals to follow official prophylactic/ therapeutic guidelines; access to antiretroviral drugs; laboratory diagnosis (HIV testing, CD4 cell count, viral load, genotype and opportunistic infections assays); recommendations against breastfeeding; offering HIV tests for all pregnant women; compulsory reporting of all HIV-positive pregnant women and of children exposed to HIV; rapid HIV tests in maternity units; and providing infant formula to all children with HIV-positive mothers [11] . These initiatives took place in the context of steadily increasing resources available for the diagnosis and treatment of HIV/AIDS (Table 1) , including universal free access to triple antiretroviral therapy starting in 1996 [16] .
These efforts represent a substantial commitment of resources for a middle-income country such as Brazil. Therefore, it is essential to measure their impact. Previous studies have reported reductions in MTCT in Brazil [12, 17, 18, 19] , but these have all been based on the experience of a single city or model clinical service. No published studies have examined results on a populationwide basis for broad geographical areas. This paper examines the available data for selected process and outcome indicators to provide an update on the current status of efforts to reduce MTCT of HIV in São Paulo State, the most populous state in Brazil and the epicentre of the Brazilian AIDS epidemic.
Methods
The present study was based on data from São Paulo State Epidemiological Surveillance, which, through the National System for Disease Control, Sistema Nacional de Agravos de Notificaça˜o (SINAN), receives and analyses reported cases of AIDS and of HIV in pregnant women and in exposed children. We included cases with a date of diagnosis to December 2002, and entered into the system by June 2004, so as to minimize reporting and entry delay bias [20] .
Data on intravenous zidovudine and on the use of rapid tests for HIV detection were provided by the São Paulo State STD/AIDS Program, which controls the purchase and distribution of these products. We compared this with the total number of deliveries per year [21] , and estimated HIV seroprevalence among women giving birth from the National Sentinel Study of HIV and the UNAIDS seroprevalence survey [22, 23] .
To evaluate the rate of MTCT of HIV in São Paulo State throughout the years, we made use of the results of two previous studies. The first study was conducted in 1995, in centres of excellence for the treatment of children exposed to and infected by HIV in four São Paulo State municipalities with populations of over 700 000 [6] . That study was a retrospective evaluation of 434 children, considering clinical, laboratory, and prophylactic aspects of mothers and children. The Brazilian Pediatric Society coordinated the second study [24] . This national collaborative study involves centres throughout the [21] . No studies to date have systematically measured the prevalence of HIV infection in pregnant women in São Paulo State; sentinel surveillance in specific sites together with smaller seroprevalence studies [22, 23] suggest an approximate prevalence of 0.5-0.6%. If correct, this would suggest between 3116 and 3739 births to HIV-positive women per year and coverage with intravenous zidovudine of between 67 and 81%.
As 85% of women receive prenatal care in São Paulo State, and are thus likely to undergo HIV testing, there remains a maximum of approximately 15% of women in need of rapid HIV testing in maternity units [11] ; in 2003, 70 600 rapid tests were utilized in 609 317 deliveries. This rate of 11.6% thus appears to approach the potential need. [26] . This reduction in AIDS cases was probably a result of a combination of reduced MTCT and the delayed progression of HIV infection to AIDS among infected children because of improved treatment.
In the United States and other developed countries, reductions in the number of MTCT-related cases have been observed since 1995 as a result of the wide coverage of HIV testing before or during pregnancy and the prompt incorporation of antiretroviral drugs in prophylaxis and in the treatment of infected pregnant women [7] [8] [9] . Similar success, however, is not being achieved by most developing countries, which to varying degrees face difficulties in implementing interventions for the prevention of MTCT as a result of logistic deficiencies and budget restrictions [27] . We conclude that, despite difficulties in the identification of the relative contribution of each of the factors presented, there has been an important reduction in the rate of MTCT of HIV in São Paulo State, comparable to that observed in developed countries. At the same time, many challenges remain. To reduce MTCT still further, it will be necessary to identify all HIV-positive pregnant women and to make certain that treatment guidelines are consistently applied. These guidelines include the replacement of breast milk by formula feeding or pasteurized human milk [11] , and increasingly recommend treating the mother (and thereby preventing MTCT) with combination antiretroviral therapy. Consistent implementation of these strategies will require continued training, quality improvement, and the monitoring of all MTCT prevention strategies, as well as multifaceted efforts to make sure that all women receive early prenatal care. Ultimately, the goal should be to come as close as possible to the elimination of MTCT of HIV.
